Ten (5.2%) physicians noted other markers as determinants of COVID-19 outcome, namely interleukin-6 (IL-6), LDH, transaminase, creatine-phospho-kinase (CPK), and procalcitonin. This evidence concerns the gene PIK3C2A and COVID-19.